Baidu
map

时占祥:机器人在医疗应用上的现状和发展前景

2015-12-18 时占祥 医谷

12月12日,在中欧国际工商学院主办的2015中国健康产业创新平台奇璞峰会上,全球医生组织北京代表处负责人时占祥就《机器人在医疗应用上的现状和发展前景》发表了演讲,认为多个观点具启发性,特根据演讲实录整理如下,难免谬误,仅供学习参考。 机器人是在解决人类社会生产力问题 最近两年关于机器人的讨论非常热烈,其中一个比较激烈的观点是人工智能或者机器人是人类在自掘坟墓,这方面,霍金多次强调了类似的

12月12日,在中欧国际工商学院主办的2015中国健康产业创新平台奇璞峰会上,全球医生组织北京代表处负责人时占祥就《机器人在医疗应用上的现状和发展前景》发表了演讲,认为多个观点具启发性,特根据演讲实录整理如下,难免谬误,仅供学习参考。

机器人是在解决人类社会生产力问题

最近两年关于机器人的讨论非常热烈,其中一个比较激烈的观点是人工智能或者机器人是人类在自掘坟墓,这方面,霍金多次强调了类似的观点。不过,从我个人的角度而言,我们研发机器人的目的,是为了什么?我们希望机器人能够聪明一点,灵巧一点,安全一点,归底结底是希望机器人能够弥补人类或者个人在某些领域的不足,帮助人类在某些不方便到达的区域工作,放大在未来10年、20年,甚至30年、50年以后,机器人其实是在解决人类社会生产力问题。


人工智能的标志不是知识而是想象

某些时候,大家会纠结一个问题,什么是智能机器人,到底什么是智能?其实在28年前,我在学医的时候,就一直在思考这个问题,我在医学院最后实习的半年,在精神病总院待了半年,有人说人类区别于动物,或者人类智慧的特点是语言,当你观察精神病人会发现精神病人经常滔滔不绝,但通常缺乏逻辑性。智能的东西不管是学习还是深度学习,你能告诉我,能不能有逻辑性。包括最近《Science》发表的一篇文章提到,机器人可以通过视觉学习识别和定位菠萝,但是如果你在菠萝中再加入一些其他事物,比如菠萝饭,酸奶中放入菠萝,面包中夹片菠萝,人工智能能分辨认识总结吗?但如果你问五岁的小孩这几样东西有什么共同的地方,他会强调都有菠萝或者菠萝味。因此我认为智能的标志不是知识,而是想象。

关于医用机器人、Robot和Humanoid

关于医用机器人,很多时候会涉及到一个问题,到底是医疗还是医用。我认为医疗是非常严格的一个科学过程或者实践过程,医用有的时候要求则可以稍微低一点,所以我把医用定义为必须实用,必须可用,而且可负担。比如英国有一个护理机器人,27万英镑,那还不如雇个人更实惠。

关于Robot和Humanoid,我认为Robot是一个智能机器或者装置,在自控程序下执行工作, Humanoid是人形机器,似有双眼,可直立行走。目前日本,包括国内有许多企业和研发机构在做这方面的研究。

关于智能机器人领域

整个智能机器人的研发和产业领域,个人归纳为四个方面:工业及制造业、教育与娱乐业、医疗与大健康产业、军事与航空航天工业。医疗与大健康领域机器人是融合了当代前沿科技和成熟产品,包括人工智能、计算机模拟、传感器、移动通讯和互联网+等,是引领21世纪医疗、养老与康复等产业前景最前沿的技术和产品。

关于医用机器人与医生的关系


个人认为,智能医用机器人不是为了取代医生,更不是为了颠覆医疗,而是为了补充医疗和健康专业人员的短缺,最终目的是为了提高医疗服务质量。

关于医用机器人的分类

个人归纳为五类,分别是:

1)远程医疗机器人;

2)护理及康复机器人;

3)智能假肢及“器官”机器人;

4)微创外科手术机器人;

5)特种功能的微型机器人。;

从投资的角度,就规模和市场而言,我认为在中国前两者要远远大于后三者。

关于远程医疗机器人

远程医疗机器人,我个人认为应具有以下的特点:

第一、可移动、简易操作、功能专业化;

第二、可以实现远程医疗服务,具有可用性、实用性、可负担;

第三、大家比较忽视的一点——智能化,包括远程遥控,可以兼容各种APP,可以学习反馈,云存储。目前我手上的手机可以在国内实现对36台机器人的控制。



从端而言,就是从PC端到手机端再到智能机器人终端的转移,最早的时候,我们都是通过计算机网络来进行远程医疗,但有个问题,就是你不能离开他,没有办法持续进行个性化的健康咨询,无法实现医患的“实景”交流。智能手机出现后,我们可以通过智能手机来进行问诊,但是手机并不是仅仅用来诊疗的,而且存储能力也有限,还存在其他不足。于是我们希望有独立终端来进行类似的操作,于是有了远程医疗机器人,并且部分设计人员希望加入测血压、血糖、血氧的功能,实际上很多东西都可以加上,但是有没有必要做得想清楚,比如汽车,一定是有它的特色,但是不是所有的汽车都要把所有的东西全放进去。

举个例子,目前,上文展示这种远程医疗机器人在国外、北京、上海已经开始实践,可以协助医护人员进行远程交流,帮助医生实现患者的个性化咨询,解决医生和患者的“实景”交流问题。


这是上海社区的一个案例。我是拿手机实拍的,老病号糖尿病血脂高了,怎么办,药怎么改,常规手段是患者转诊上去到上面看内分泌科的专科医生,但是真正转上去以后,上面的主任说这种病你转上来干吗,我告诉你怎么回事,把药换了就行。所以这就是一个远程咨询,首先上面的主任跟患者进行交流,什么情况,以后要注意什么,然后跟全科医生讲,该用什么药,三方5分钟之内就可以把问题解决。这一方面实现了社区医生的学习,另一方面也省去了患者转诊带来的诸多不便,如果这种方式可以推而广之,全国实现,可以节省三甲医院大量的医疗资源。


再举一个例子,比如康复护理机器人中有一类叫外骨骼可穿戴机器人。中国每年有300万人中风,这时候遇到一个问题,如果要到医院去做康复理疗,每个人至少要带一个家属,但通过这样的外骨骼可穿戴机器人,就可以实现自理,对于残疾人而言,依然适用。

再比如护理机器人,可能有人会想到陪老年人聊天、情感看护、喂饭等,但其实目前一些护理机器人功能很单一,但却很好的解决了实际问题,比如病人移动、老年人起夜去洗手间等。日本松下曾做过一个市场调研,未来五年,该类型的机器人市场规模将会扩大十倍。

关于达芬奇手术机器人


目前,达芬奇手术机器人已经发展到了第四代,被认为是最成功的典范,相比第三代,第四代达芬奇手术机器人除了操作软件等方面进行了改进,安全性也更好。国内也有很多企业准备进行这块的研发。但我认为不需要做,或者说是过时的,因为第六代、第七代机器人不是这样的。

第一、达芬奇手术机器人功能太多,可以满足妇产科、泌尿外科、普外科等多个科室的手术,但如果一个医院只购置一台,那么到底哪个科室先用,谁用,可能就会出现很多问题。

第二、因为功能太多,相应的造价就很贵。目前国内大概是2000多万人民币,美国大概是200万美元左右,还有维持费,17万美元,大概100万人民币/年。

此外、达芬奇公司可以通过其手术机器人和3D模拟机不断获得最新医生的操作数据和问题,并实现改进,作为后来者很难跟上其研发的脚步。

这就提示我们首先要解决差异性。我认为微创手术的差异性是专科化、专项化,甚至专手术。骨科做什么,神经外科做什么,普外科、妇产科以及泌尿外科做什么,所有都可以单独做,可以单独设置一个专门的手术中心来解决相应的问题。将来的趋势,真正微创外科手术机器人应该是分拆式的,而不是结合在一起,因为原理是相同,都是建立在一个平台上的,只需要满足单独的功能即可,这样手术机器人的价格就也可以降下来。

未来的微创手术机器人应该是功能分明,突出细分化应用,按照手术流程可大到机体外科手术、小到简单伤口缝合,将突破达芬奇机器人垄断的局面,包括蛇形单臂机器人、手术定位和导航机器人、直到更强大的人工智能DIY医用机器人平台和智能化OR系统。

关于3D模拟机

对于医生而言,微创手术机器人最大的问题是学习和掌握熟练的操作,这就必不可少的需要进行3D模拟训练,正如飞行员在真正上飞机之前要进行模拟飞行训练。


3D模拟机应可以实现老师手术录制的转化,当老师做完一台手术后,其录制视频可以通过转化成为3D模拟机的一个课件,教程,学生可以通过比对模拟来实现有针对性的指导和提高。同时通过模拟机,我们可以收集医生在实践中可能患的错误,从而实现改进。

关于特种功能微型机器人


一个方向是诊断机器人,比如做直肠活检,目前的方法夹子夹在上面是很不舒服的,但通过微型机器人却可以减轻或取代这样的痛苦。

阻碍医用机器人发展的障碍

有些人认为机器人发展的障碍是传感器问题,智能问题,我认为以下两个问题如果无法解决,机器人产业也无法发展起来。

第一是无线通讯技术,目前我们用的是WiFi,其传输速度和稳定性无法解决医疗过程中的实际需求,一种方案是借助照明光源打造LiFi,只要有灯光就可以,网络上传下载速度可以达到1GB/秒,这应该有可能弥补和解决机器人的动力源和网络问题。

第二个技术是全谱相机,机器人可以借助它实现可见光、红外线到紫外线全光谱视觉的覆盖。

3米之外即远程


这是去年西非埃博拉,家属不幸被传染,小孩被医疗隔离,通过远程医疗机器人可以减少医护人员被感染和死亡的风险。再比如,今年在北京传染病医院的观察室也使用了这样的机器。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (11)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1981436, encodeId=c7111981436bb, content=<a href='/topic/show?id=58f33e82652' target=_blank style='color:#2F92EE;'>#发展前景#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37826, encryptionId=58f33e82652, topicName=发展前景)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sun Sep 04 02:37:00 CST 2016, time=2016-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48243, encodeId=b69c4824344, content=值得看,好好收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 16:05:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321873, encodeId=1c2313218e38d, content=<a href='/topic/show?id=890c611854e' target=_blank style='color:#2F92EE;'>#机器人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61185, encryptionId=890c611854e, topicName=机器人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Sun Dec 20 13:37:00 CST 2015, time=2015-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582930, encodeId=b5611582930f9, content=<a href='/topic/show?id=f6e1611840d' target=_blank style='color:#2F92EE;'>#机器#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61184, encryptionId=f6e1611840d, topicName=机器)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13dc16973127, createdName=ms6279672939590805, createdTime=Sun Dec 20 13:37:00 CST 2015, time=2015-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46804, encodeId=64864680479, content=赞~, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec6488436, createdName=a191008346, createdTime=Sun Dec 20 09:00:00 CST 2015, time=2015-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46732, encodeId=8fbb46e32ce, content=医用, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=121e1622385, createdName=chenhui888, createdTime=Sat Dec 19 13:16:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46725, encodeId=bebe46e2568, content=挺不错的, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151016/IMG56205A89715F55916.jpg, createdBy=23dd1656569, createdName=Wei Junhui, createdTime=Sat Dec 19 11:42:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46711, encodeId=e2da46e11c5, content=发展真的很快, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sat Dec 19 11:30:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46706, encodeId=d91846e0650, content=是个趋势!, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150714/IMG55A4BC357ED6E1444.jpg, createdBy=9f231612624, createdName=liushui8012, createdTime=Sat Dec 19 07:58:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46705, encodeId=78cd46e05d8, content=值得学习。, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Sat Dec 19 07:26:00 CST 2015, time=2015-12-19, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1981436, encodeId=c7111981436bb, content=<a href='/topic/show?id=58f33e82652' target=_blank style='color:#2F92EE;'>#发展前景#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37826, encryptionId=58f33e82652, topicName=发展前景)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sun Sep 04 02:37:00 CST 2016, time=2016-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48243, encodeId=b69c4824344, content=值得看,好好收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 16:05:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321873, encodeId=1c2313218e38d, content=<a href='/topic/show?id=890c611854e' target=_blank style='color:#2F92EE;'>#机器人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61185, encryptionId=890c611854e, topicName=机器人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Sun Dec 20 13:37:00 CST 2015, time=2015-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582930, encodeId=b5611582930f9, content=<a href='/topic/show?id=f6e1611840d' target=_blank style='color:#2F92EE;'>#机器#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61184, encryptionId=f6e1611840d, topicName=机器)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13dc16973127, createdName=ms6279672939590805, createdTime=Sun Dec 20 13:37:00 CST 2015, time=2015-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46804, encodeId=64864680479, content=赞~, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec6488436, createdName=a191008346, createdTime=Sun Dec 20 09:00:00 CST 2015, time=2015-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46732, encodeId=8fbb46e32ce, content=医用, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=121e1622385, createdName=chenhui888, createdTime=Sat Dec 19 13:16:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46725, encodeId=bebe46e2568, content=挺不错的, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151016/IMG56205A89715F55916.jpg, createdBy=23dd1656569, createdName=Wei Junhui, createdTime=Sat Dec 19 11:42:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46711, encodeId=e2da46e11c5, content=发展真的很快, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sat Dec 19 11:30:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46706, encodeId=d91846e0650, content=是个趋势!, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150714/IMG55A4BC357ED6E1444.jpg, createdBy=9f231612624, createdName=liushui8012, createdTime=Sat Dec 19 07:58:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46705, encodeId=78cd46e05d8, content=值得学习。, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Sat Dec 19 07:26:00 CST 2015, time=2015-12-19, status=1, ipAttribution=)]
    2015-12-26 hixiaoluo

    值得看,好好收藏

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1981436, encodeId=c7111981436bb, content=<a href='/topic/show?id=58f33e82652' target=_blank style='color:#2F92EE;'>#发展前景#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37826, encryptionId=58f33e82652, topicName=发展前景)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sun Sep 04 02:37:00 CST 2016, time=2016-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48243, encodeId=b69c4824344, content=值得看,好好收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 16:05:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321873, encodeId=1c2313218e38d, content=<a href='/topic/show?id=890c611854e' target=_blank style='color:#2F92EE;'>#机器人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61185, encryptionId=890c611854e, topicName=机器人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Sun Dec 20 13:37:00 CST 2015, time=2015-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582930, encodeId=b5611582930f9, content=<a href='/topic/show?id=f6e1611840d' target=_blank style='color:#2F92EE;'>#机器#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61184, encryptionId=f6e1611840d, topicName=机器)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13dc16973127, createdName=ms6279672939590805, createdTime=Sun Dec 20 13:37:00 CST 2015, time=2015-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46804, encodeId=64864680479, content=赞~, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec6488436, createdName=a191008346, createdTime=Sun Dec 20 09:00:00 CST 2015, time=2015-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46732, encodeId=8fbb46e32ce, content=医用, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=121e1622385, createdName=chenhui888, createdTime=Sat Dec 19 13:16:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46725, encodeId=bebe46e2568, content=挺不错的, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151016/IMG56205A89715F55916.jpg, createdBy=23dd1656569, createdName=Wei Junhui, createdTime=Sat Dec 19 11:42:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46711, encodeId=e2da46e11c5, content=发展真的很快, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sat Dec 19 11:30:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46706, encodeId=d91846e0650, content=是个趋势!, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150714/IMG55A4BC357ED6E1444.jpg, createdBy=9f231612624, createdName=liushui8012, createdTime=Sat Dec 19 07:58:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46705, encodeId=78cd46e05d8, content=值得学习。, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Sat Dec 19 07:26:00 CST 2015, time=2015-12-19, status=1, ipAttribution=)]
    2015-12-20 xue8602
  4. [GetPortalCommentsPageByObjectIdResponse(id=1981436, encodeId=c7111981436bb, content=<a href='/topic/show?id=58f33e82652' target=_blank style='color:#2F92EE;'>#发展前景#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37826, encryptionId=58f33e82652, topicName=发展前景)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sun Sep 04 02:37:00 CST 2016, time=2016-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48243, encodeId=b69c4824344, content=值得看,好好收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 16:05:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321873, encodeId=1c2313218e38d, content=<a href='/topic/show?id=890c611854e' target=_blank style='color:#2F92EE;'>#机器人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61185, encryptionId=890c611854e, topicName=机器人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Sun Dec 20 13:37:00 CST 2015, time=2015-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582930, encodeId=b5611582930f9, content=<a href='/topic/show?id=f6e1611840d' target=_blank style='color:#2F92EE;'>#机器#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61184, encryptionId=f6e1611840d, topicName=机器)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13dc16973127, createdName=ms6279672939590805, createdTime=Sun Dec 20 13:37:00 CST 2015, time=2015-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46804, encodeId=64864680479, content=赞~, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec6488436, createdName=a191008346, createdTime=Sun Dec 20 09:00:00 CST 2015, time=2015-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46732, encodeId=8fbb46e32ce, content=医用, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=121e1622385, createdName=chenhui888, createdTime=Sat Dec 19 13:16:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46725, encodeId=bebe46e2568, content=挺不错的, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151016/IMG56205A89715F55916.jpg, createdBy=23dd1656569, createdName=Wei Junhui, createdTime=Sat Dec 19 11:42:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46711, encodeId=e2da46e11c5, content=发展真的很快, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sat Dec 19 11:30:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46706, encodeId=d91846e0650, content=是个趋势!, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150714/IMG55A4BC357ED6E1444.jpg, createdBy=9f231612624, createdName=liushui8012, createdTime=Sat Dec 19 07:58:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46705, encodeId=78cd46e05d8, content=值得学习。, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Sat Dec 19 07:26:00 CST 2015, time=2015-12-19, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1981436, encodeId=c7111981436bb, content=<a href='/topic/show?id=58f33e82652' target=_blank style='color:#2F92EE;'>#发展前景#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37826, encryptionId=58f33e82652, topicName=发展前景)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sun Sep 04 02:37:00 CST 2016, time=2016-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48243, encodeId=b69c4824344, content=值得看,好好收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 16:05:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321873, encodeId=1c2313218e38d, content=<a href='/topic/show?id=890c611854e' target=_blank style='color:#2F92EE;'>#机器人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61185, encryptionId=890c611854e, topicName=机器人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Sun Dec 20 13:37:00 CST 2015, time=2015-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582930, encodeId=b5611582930f9, content=<a href='/topic/show?id=f6e1611840d' target=_blank style='color:#2F92EE;'>#机器#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61184, encryptionId=f6e1611840d, topicName=机器)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13dc16973127, createdName=ms6279672939590805, createdTime=Sun Dec 20 13:37:00 CST 2015, time=2015-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46804, encodeId=64864680479, content=赞~, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec6488436, createdName=a191008346, createdTime=Sun Dec 20 09:00:00 CST 2015, time=2015-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46732, encodeId=8fbb46e32ce, content=医用, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=121e1622385, createdName=chenhui888, createdTime=Sat Dec 19 13:16:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46725, encodeId=bebe46e2568, content=挺不错的, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151016/IMG56205A89715F55916.jpg, createdBy=23dd1656569, createdName=Wei Junhui, createdTime=Sat Dec 19 11:42:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46711, encodeId=e2da46e11c5, content=发展真的很快, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sat Dec 19 11:30:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46706, encodeId=d91846e0650, content=是个趋势!, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150714/IMG55A4BC357ED6E1444.jpg, createdBy=9f231612624, createdName=liushui8012, createdTime=Sat Dec 19 07:58:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46705, encodeId=78cd46e05d8, content=值得学习。, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Sat Dec 19 07:26:00 CST 2015, time=2015-12-19, status=1, ipAttribution=)]
    2015-12-20 a191008346

    赞~

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1981436, encodeId=c7111981436bb, content=<a href='/topic/show?id=58f33e82652' target=_blank style='color:#2F92EE;'>#发展前景#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37826, encryptionId=58f33e82652, topicName=发展前景)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sun Sep 04 02:37:00 CST 2016, time=2016-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48243, encodeId=b69c4824344, content=值得看,好好收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 16:05:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321873, encodeId=1c2313218e38d, content=<a href='/topic/show?id=890c611854e' target=_blank style='color:#2F92EE;'>#机器人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61185, encryptionId=890c611854e, topicName=机器人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Sun Dec 20 13:37:00 CST 2015, time=2015-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582930, encodeId=b5611582930f9, content=<a href='/topic/show?id=f6e1611840d' target=_blank style='color:#2F92EE;'>#机器#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61184, encryptionId=f6e1611840d, topicName=机器)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13dc16973127, createdName=ms6279672939590805, createdTime=Sun Dec 20 13:37:00 CST 2015, time=2015-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46804, encodeId=64864680479, content=赞~, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec6488436, createdName=a191008346, createdTime=Sun Dec 20 09:00:00 CST 2015, time=2015-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46732, encodeId=8fbb46e32ce, content=医用, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=121e1622385, createdName=chenhui888, createdTime=Sat Dec 19 13:16:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46725, encodeId=bebe46e2568, content=挺不错的, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151016/IMG56205A89715F55916.jpg, createdBy=23dd1656569, createdName=Wei Junhui, createdTime=Sat Dec 19 11:42:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46711, encodeId=e2da46e11c5, content=发展真的很快, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sat Dec 19 11:30:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46706, encodeId=d91846e0650, content=是个趋势!, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150714/IMG55A4BC357ED6E1444.jpg, createdBy=9f231612624, createdName=liushui8012, createdTime=Sat Dec 19 07:58:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46705, encodeId=78cd46e05d8, content=值得学习。, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Sat Dec 19 07:26:00 CST 2015, time=2015-12-19, status=1, ipAttribution=)]
    2015-12-19 chenhui888

    医用

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1981436, encodeId=c7111981436bb, content=<a href='/topic/show?id=58f33e82652' target=_blank style='color:#2F92EE;'>#发展前景#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37826, encryptionId=58f33e82652, topicName=发展前景)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sun Sep 04 02:37:00 CST 2016, time=2016-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48243, encodeId=b69c4824344, content=值得看,好好收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 16:05:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321873, encodeId=1c2313218e38d, content=<a href='/topic/show?id=890c611854e' target=_blank style='color:#2F92EE;'>#机器人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61185, encryptionId=890c611854e, topicName=机器人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Sun Dec 20 13:37:00 CST 2015, time=2015-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582930, encodeId=b5611582930f9, content=<a href='/topic/show?id=f6e1611840d' target=_blank style='color:#2F92EE;'>#机器#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61184, encryptionId=f6e1611840d, topicName=机器)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13dc16973127, createdName=ms6279672939590805, createdTime=Sun Dec 20 13:37:00 CST 2015, time=2015-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46804, encodeId=64864680479, content=赞~, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec6488436, createdName=a191008346, createdTime=Sun Dec 20 09:00:00 CST 2015, time=2015-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46732, encodeId=8fbb46e32ce, content=医用, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=121e1622385, createdName=chenhui888, createdTime=Sat Dec 19 13:16:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46725, encodeId=bebe46e2568, content=挺不错的, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151016/IMG56205A89715F55916.jpg, createdBy=23dd1656569, createdName=Wei Junhui, createdTime=Sat Dec 19 11:42:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46711, encodeId=e2da46e11c5, content=发展真的很快, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sat Dec 19 11:30:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46706, encodeId=d91846e0650, content=是个趋势!, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150714/IMG55A4BC357ED6E1444.jpg, createdBy=9f231612624, createdName=liushui8012, createdTime=Sat Dec 19 07:58:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46705, encodeId=78cd46e05d8, content=值得学习。, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Sat Dec 19 07:26:00 CST 2015, time=2015-12-19, status=1, ipAttribution=)]
    2015-12-19 Wei Junhui

    挺不错的

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1981436, encodeId=c7111981436bb, content=<a href='/topic/show?id=58f33e82652' target=_blank style='color:#2F92EE;'>#发展前景#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37826, encryptionId=58f33e82652, topicName=发展前景)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sun Sep 04 02:37:00 CST 2016, time=2016-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48243, encodeId=b69c4824344, content=值得看,好好收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 16:05:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321873, encodeId=1c2313218e38d, content=<a href='/topic/show?id=890c611854e' target=_blank style='color:#2F92EE;'>#机器人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61185, encryptionId=890c611854e, topicName=机器人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Sun Dec 20 13:37:00 CST 2015, time=2015-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582930, encodeId=b5611582930f9, content=<a href='/topic/show?id=f6e1611840d' target=_blank style='color:#2F92EE;'>#机器#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61184, encryptionId=f6e1611840d, topicName=机器)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13dc16973127, createdName=ms6279672939590805, createdTime=Sun Dec 20 13:37:00 CST 2015, time=2015-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46804, encodeId=64864680479, content=赞~, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec6488436, createdName=a191008346, createdTime=Sun Dec 20 09:00:00 CST 2015, time=2015-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46732, encodeId=8fbb46e32ce, content=医用, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=121e1622385, createdName=chenhui888, createdTime=Sat Dec 19 13:16:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46725, encodeId=bebe46e2568, content=挺不错的, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151016/IMG56205A89715F55916.jpg, createdBy=23dd1656569, createdName=Wei Junhui, createdTime=Sat Dec 19 11:42:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46711, encodeId=e2da46e11c5, content=发展真的很快, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sat Dec 19 11:30:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46706, encodeId=d91846e0650, content=是个趋势!, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150714/IMG55A4BC357ED6E1444.jpg, createdBy=9f231612624, createdName=liushui8012, createdTime=Sat Dec 19 07:58:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46705, encodeId=78cd46e05d8, content=值得学习。, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Sat Dec 19 07:26:00 CST 2015, time=2015-12-19, status=1, ipAttribution=)]
    2015-12-19 medcardio

    发展真的很快

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1981436, encodeId=c7111981436bb, content=<a href='/topic/show?id=58f33e82652' target=_blank style='color:#2F92EE;'>#发展前景#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37826, encryptionId=58f33e82652, topicName=发展前景)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sun Sep 04 02:37:00 CST 2016, time=2016-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48243, encodeId=b69c4824344, content=值得看,好好收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 16:05:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321873, encodeId=1c2313218e38d, content=<a href='/topic/show?id=890c611854e' target=_blank style='color:#2F92EE;'>#机器人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61185, encryptionId=890c611854e, topicName=机器人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Sun Dec 20 13:37:00 CST 2015, time=2015-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582930, encodeId=b5611582930f9, content=<a href='/topic/show?id=f6e1611840d' target=_blank style='color:#2F92EE;'>#机器#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61184, encryptionId=f6e1611840d, topicName=机器)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13dc16973127, createdName=ms6279672939590805, createdTime=Sun Dec 20 13:37:00 CST 2015, time=2015-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46804, encodeId=64864680479, content=赞~, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec6488436, createdName=a191008346, createdTime=Sun Dec 20 09:00:00 CST 2015, time=2015-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46732, encodeId=8fbb46e32ce, content=医用, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=121e1622385, createdName=chenhui888, createdTime=Sat Dec 19 13:16:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46725, encodeId=bebe46e2568, content=挺不错的, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151016/IMG56205A89715F55916.jpg, createdBy=23dd1656569, createdName=Wei Junhui, createdTime=Sat Dec 19 11:42:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46711, encodeId=e2da46e11c5, content=发展真的很快, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sat Dec 19 11:30:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46706, encodeId=d91846e0650, content=是个趋势!, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150714/IMG55A4BC357ED6E1444.jpg, createdBy=9f231612624, createdName=liushui8012, createdTime=Sat Dec 19 07:58:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46705, encodeId=78cd46e05d8, content=值得学习。, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Sat Dec 19 07:26:00 CST 2015, time=2015-12-19, status=1, ipAttribution=)]
    2015-12-19 liushui8012

    是个趋势!

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1981436, encodeId=c7111981436bb, content=<a href='/topic/show?id=58f33e82652' target=_blank style='color:#2F92EE;'>#发展前景#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37826, encryptionId=58f33e82652, topicName=发展前景)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sun Sep 04 02:37:00 CST 2016, time=2016-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48243, encodeId=b69c4824344, content=值得看,好好收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 16:05:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321873, encodeId=1c2313218e38d, content=<a href='/topic/show?id=890c611854e' target=_blank style='color:#2F92EE;'>#机器人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61185, encryptionId=890c611854e, topicName=机器人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Sun Dec 20 13:37:00 CST 2015, time=2015-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582930, encodeId=b5611582930f9, content=<a href='/topic/show?id=f6e1611840d' target=_blank style='color:#2F92EE;'>#机器#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61184, encryptionId=f6e1611840d, topicName=机器)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13dc16973127, createdName=ms6279672939590805, createdTime=Sun Dec 20 13:37:00 CST 2015, time=2015-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46804, encodeId=64864680479, content=赞~, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec6488436, createdName=a191008346, createdTime=Sun Dec 20 09:00:00 CST 2015, time=2015-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46732, encodeId=8fbb46e32ce, content=医用, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=121e1622385, createdName=chenhui888, createdTime=Sat Dec 19 13:16:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46725, encodeId=bebe46e2568, content=挺不错的, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151016/IMG56205A89715F55916.jpg, createdBy=23dd1656569, createdName=Wei Junhui, createdTime=Sat Dec 19 11:42:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46711, encodeId=e2da46e11c5, content=发展真的很快, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sat Dec 19 11:30:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46706, encodeId=d91846e0650, content=是个趋势!, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150714/IMG55A4BC357ED6E1444.jpg, createdBy=9f231612624, createdName=liushui8012, createdTime=Sat Dec 19 07:58:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46705, encodeId=78cd46e05d8, content=值得学习。, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Sat Dec 19 07:26:00 CST 2015, time=2015-12-19, status=1, ipAttribution=)]
    2015-12-19 dhzzm

    值得学习。

    0

相关资讯

机器人如果接管医疗界,医生何去何从?

机器人药剂师能够进行配药;纳米机器人能够管理针对癌症和其他疾病的治疗情况;有些机器人能够帮助诊断疾病,如协助子宫颈抹片的检查;其他一些则能够有效地为老年人提供24小时护理;手术机器人是一个价值数十亿美元的产业……根据Association of Academic Health Centers的总裁兼CEO Steven Wartman博士的说法,在当今,一个一直出现于科幻小说中的场

移动医疗机器人在社区医院得到应用

最近,移动医疗机器人在上海社区医院得到应用,社区医院看病可以依靠它了。 在浦东南汇的社区卫生服务中心,与社区医生一同出诊的,竟还有机器人。借助远程传输技术,电脑屏幕会接通上级医院医生一同讨论病情。这是浦东医院从美国最新引进的移动医疗机器人,据此,优质医疗资源打破了地域限制。  基于分级诊疗这个关键词,作为我国最基层医疗体系的社区,已出现、并还会出现许多翻天覆地的变化。近日在沪举行的“20

手术机器人“达芬奇系统”精巧缝合葡萄皮 令人叹止!

“达芬奇系统”手术机器人,其实作为临床医生都听说过,而且在国内,已有很多台了,在多种难处理的手术中得到成功应用。然而,非外科医生,还是很难想象它的奇妙之处。作为当今世界上最先进的微创外科技术平台,到底有何神通?另外,为什么要把这套手术机器人命名为达芬奇,因为制造者认为达·芬奇于1495年即设计了仿人型机械,因此是世界上第一台机器人的发明者。 该系统充分结合了美国航天航空局和众多研究机

机器人发展史(公元前1400-公元2015年),2045年有望超越人类

其实当今社会,我们人类已经在很多方面都离不开机器人的帮助。奇点大学校长库兹韦尔(Ray Kurzweil)认为,2045年是奇点时代的元年,在那年机器的智慧首次超过人类,机器将全面取代人类事务。摆在人类面前的只有两条道路:与机器融合,或者被机器毁灭。对于人类这一前景,目前业界说法不一。在日本,机器人已正在走进千家万户。就移动医疗而言,日本没有大量的所谓的轻问诊公司,但是却有大量的医疗机器人问世

FDA:机器人已经可以给人做手术了

Flex®机器人系统。设计基于卡耐基梅隆大学的Howie Choset。这款通过口腔的进入人体的机器人能够让外科医生看到并且能够到达非常难到达的解剖区域。来自卡耐基梅隆大学的公司Medrobotics Corp.于2015年7月下旬发表声明,称其公司生产的Flex®机器人系统已经得到美国食品及药物管理局(FDA)的放行,可以在市场上销售了。这款机器人的设计基于该大学的机器人研究所的Howie Ch

医生,把助理工作交给这10个机器人吧!

机器人对于医疗保健行业并不陌生。我们知道,已经有大量的机器人被用于各种物理治疗中,还有一些机器人被用于帮助训练医生进行一系列治疗和手术。下面这10个机器人是当前最实用的医用机器人,它们有潜力为医疗产业带来革命。 1. Vasteras Giraff Vasteras Giraff相当于是一个移动通信工具,让老年人可以与外界通信。它是个由轮子、摄像头和显示器组成的家伙,可以通过遥

Baidu
map
Baidu
map
Baidu
map